Trial Profile
A randomized, double-blinded, placebo-controlled, crossover study of 5-aminolevulinic acid in the prevention of migraine
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 06 Oct 2015 New trial record